Luminex Corporation Achieves Milestone by Shipping its 10,000th Instrument

Luminex Corporation has announced it has passed a major milestone by shipping its 10,000th multiplexing instrument. This milestone was achieved by shipping a MAGPIX® instrument to Dr. Kimberle Chapin at the Rhode Island Hospital in Providence, R.I., the largest hospital and only Level I trauma center in the state. This MAGPIX instrument will be used initially for assay validation of Luminex's xTAG® Gastrointestinal Pathogen Panel.

"Shipping our 10,000th instrument is an achievement that every Luminex employee is very proud of," said Patrick J. Balthrop, president and chief executive officer of Luminex. "The substantial installed base of Luminex instruments is a testament to the flexibility of our xMAP® Technology and to the open architecture upon which our customers and partners can build their assays. It is gratifying to know that our 10,000th instrument will be used by Dr. Kimberle Chapin and her excellent team. The ability to streamline gastroenteritis testing and deliver comprehensive, timely results is important to laboratories across the country."

Since shipping its first Luminex® 100™ multiplexing instrument, Luminex has continued to drive innovation in multiplexing products and services to the global healthcare and life science research communities. Luminex is known for developing many first-to-market molecular assays, such as the first multiplex cystic fibrosis assay, the first respiratory viral panel and most recently the first gastrointestinal pathogen panel. Luminex's portfolio of multiplexing instruments and assays addresses a broad range of laboratory and budgetary needs for life science research, clinical diagnostics, and biosurveillance. The instrument line includes the 100-plex Luminex 100/200, the economical 50-plex MAGPIX and the high-throughput, 500-plex FLEXMAP 3D® systems.

Rhode Island Hospital is the principal teaching hospital of The Warren Alpert Medical School of Brown University.